• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与接受抗结核治疗的HIV感染者死亡率、严重发病率及治疗失败相关的结核病疾病特征——ANRS 12300 Reflate TB2试验的二次分析

Tuberculosis disease characteristics associated with mortality, severe morbidity and unsuccessful treatment in people living with HIV treated for tuberculosis - a secondary analysis of the ANRS 12300 Reflate TB2 trial.

作者信息

Akpata Robert, Ntakpe Jean-Baptiste, Messou Eugène, De Castro Nathalie, Chazallon Corine, Timana Isabel, Escada Rodrigo, Cardoso Sandra Wagner, Bhatt Nilesh, Khosa Celso, Laureillard Didier, Do Chau Giang, Nogbou Frédéric Ello, Glao Donald Diomande, Veloso Valdilea, Molina Jean-Michel, Grinsztejn Beatriz, Zannou Marcel, Eholie Serge, Marcy Olivier

机构信息

University of Bordeaux, National Institute for Health and Medical Research (Inserm) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Centre, 146 Rue Léo Saignat, Bordeaux, 33000, France.

Programme PACCI/ANRS Research Center, Abidjan, Côte d'Ivoire.

出版信息

BMC Infect Dis. 2025 May 14;25(1):695. doi: 10.1186/s12879-025-10986-4.

DOI:10.1186/s12879-025-10986-4
PMID:40361016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12077038/
Abstract

BACKGROUND

Tuberculosis is a severe disease, not only due to its lethality but also to a significant morbidity occurring in people living with HIV (PLWH). If factors associated to mortality, severe morbidity and unsuccessful treatment related to the host are well identified in PLWH, there is scarce knowledge on factors related to the disease itself such as bacillary load, extent of lung involvement and disease dissemination to other organs. We sought to assess whether tuberculosis-related factors were associated with key patient outcomes in PLWH using data from an international clinical trial.

METHODS

We conducted a secondary analysis of the ANRS 12300 Reflate TB2, an international phase III open-label randomized trial that assessed different antiretroviral regimens in PLWH treated for tuberculosis. We evaluated whether bacillary load (smear positivity grade), extent of lung involvement (cavitation on chest x-ray) and disease dissemination (urine LAM positivity) were associated with mortality using Cox proportional hazard models, and to severe morbidity and unsuccessful tuberculosis treatment using logistic regressions.

RESULTS

Of 457 participants included in this study, 90 (20.4%) had grade 2 + or 3 + smear positivity, 39 (10.8%) had cavitation on chest X-ray, and 147 (32.2%) had a positive urinary LAM. Overall, 19 (4.2%) participants died, 113 (24.7%) presented severe morbidity, and 33 (7.2%) had unsuccessful tuberculosis treatment. Factors that remained independently associated with mortality were cavitation on chest x-ray (aHR = 7.92, 95% CI, 1.74-35.94, p = .0073) and LAM positivity (aHR = 5.53, 95% CI, 1.09-28.06, p = .0389). The only factor that remained significantly associated with severe morbidity was LAM positivity (aOR = 2.04, 95% CI, 1.06-3.92, p = .0323). No factor remained significantly associated with unsuccessful tuberculosis treatment.

CONCLUSIONS

In PLWH with tuberculosis enrolled in a trial, tuberculosis disease characteristics related to disease severity were cavitation on chest x-ray and urine LAM positivity. Early identification of these factors could help improve the management of PLWH with tuberculosis and improve their survival.

摘要

背景

结核病是一种严重疾病,不仅因其致死性,还因其在艾滋病毒感染者(PLWH)中引发的显著发病率。虽然与艾滋病毒感染者死亡率、严重发病率及治疗失败相关的宿主因素已得到充分认识,但对于与疾病本身相关的因素,如细菌载量、肺部受累程度及疾病向其他器官的播散,了解却很少。我们试图利用一项国际临床试验的数据,评估结核病相关因素是否与艾滋病毒感染者的关键患者结局相关。

方法

我们对ANRS 12300 Reflate TB2进行了二次分析,这是一项国际III期开放标签随机试验,评估了接受结核病治疗的艾滋病毒感染者的不同抗逆转录病毒治疗方案。我们使用Cox比例风险模型评估细菌载量(涂片阳性分级)、肺部受累程度(胸部X线片上的空洞形成)和疾病播散(尿液脂阿拉伯甘露聚糖阳性)是否与死亡率相关,并使用逻辑回归评估其与严重发病率和结核病治疗失败的关系。

结果

本研究纳入的457名参与者中,90名(20.4%)涂片阳性分级为2级及以上或3级及以上,39名(10.8%)胸部X线片有空洞形成,147名(32.2%)尿液脂阿拉伯甘露聚糖阳性。总体而言,19名(4.2%)参与者死亡,113名(24.7%)出现严重发病率,33名(7.2%)结核病治疗失败。与死亡率独立相关的因素是胸部X线片有空洞形成(调整后风险比[aHR]=7.92,95%置信区间[CI]为1.74 - 35.94,p = 0.0073)和脂阿拉伯甘露聚糖阳性(aHR = 5.53,95% CI为1.09 - 28.06,p = 0.0389)。与严重发病率仍显著相关的唯一因素是脂阿拉伯甘露聚糖阳性(调整后比值比[aOR]=2.04,95% CI为1.06 - 3.92,p = 0.0323)。没有因素与结核病治疗失败仍显著相关。

结论

在参与试验的艾滋病毒感染结核病患者中,与疾病严重程度相关的结核病疾病特征是胸部X线片有空洞形成和尿液脂阿拉伯甘露聚糖阳性。早期识别这些因素有助于改善艾滋病毒感染结核病患者的管理并提高其生存率。

相似文献

1
Tuberculosis disease characteristics associated with mortality, severe morbidity and unsuccessful treatment in people living with HIV treated for tuberculosis - a secondary analysis of the ANRS 12300 Reflate TB2 trial.与接受抗结核治疗的HIV感染者死亡率、严重发病率及治疗失败相关的结核病疾病特征——ANRS 12300 Reflate TB2试验的二次分析
BMC Infect Dis. 2025 May 14;25(1):695. doi: 10.1186/s12879-025-10986-4.
2
Accuracy of the tuberculosis point-of-care Alere determine lipoarabinomannan antigen diagnostic test using α-mannosidase treated and untreated urine in a cohort of people living with HIV in Guatemala. Guatemalteca 队列研究:α-甘露糖苷酶处理和未处理尿液中结核感染即时检测 Alere 试剂盒检测脂阿拉伯甘露聚糖抗原的准确性。
AIDS Res Ther. 2020 Oct 19;17(1):62. doi: 10.1186/s12981-020-00318-8.
3
Impact of diagnostic strategies for tuberculosis using lateral flow urine lipoarabinomannan assay in people living with HIV.基于尿液脂阿拉伯甘露聚糖侧流检测的结核诊断策略对 HIV 感染者的影响。
Cochrane Database Syst Rev. 2021 Aug 20;8(8):CD014641. doi: 10.1002/14651858.CD014641.
4
Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial.感染艾滋病毒的成年结核病患者的死亡原因及决定因素:来自CAMELIA ANRS 1295-CIPRA KH001随机试验的分析
Clin Infect Dis. 2014 Aug 1;59(3):435-45. doi: 10.1093/cid/ciu283. Epub 2014 Apr 23.
5
Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial.基于即时检测的尿液脂阿拉伯甘露聚糖检测对指导 HIV 阳性住院患者启动结核病治疗的效果:一项在多国进行的实用、平行分组、开放标签、随机对照试验。
Lancet. 2016 Mar 19;387(10024):1187-97. doi: 10.1016/S0140-6736(15)01092-2. Epub 2016 Mar 10.
6
Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology.乌干达艾滋病毒感染涂片阴性疑似结核病患者中结核分枝杆菌培养阳性的预测因素:新型结核病诊断技术的应用
PLoS One. 2015 Jul 29;10(7):e0133756. doi: 10.1371/journal.pone.0133756. eCollection 2015.
7
Radiographic characteristics of rifampicin-resistant tuberculosis in the STREAM stage 1 trial and their influence on time to culture conversion in the short regimen.STREET 阶段 1 试验中利福平耐药结核病的放射学特征及其对短程方案中培养物转换时间的影响。
BMC Infect Dis. 2024 Jan 30;24(1):144. doi: 10.1186/s12879-024-09039-z.
8
Evaluation of a point-of-care tuberculosis test-and-treat algorithm on early mortality in people with HIV accessing antiretroviral therapy (TB Fast Track study): study protocol for a cluster randomised controlled trial.评估即时检测和治疗算法对接受抗逆转录病毒治疗的艾滋病毒感染者早期死亡率的影响(结核病快速通道研究):一项整群随机对照试验的研究方案
Trials. 2015 Mar 28;16:125. doi: 10.1186/s13063-015-0650-0.
9
Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults.HIV 感染者结核病的系统或试验指导治疗。
N Engl J Med. 2020 Jun 18;382(25):2397-2410. doi: 10.1056/NEJMoa1910708.
10
Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial.拉替拉韦治疗 HIV 和结核分枝杆菌合并感染患者(ANRS 12 180 Reflate TB):一项多中心、2 期、非对照、开放标签、随机试验。
Lancet Infect Dis. 2014 Jun;14(6):459-67. doi: 10.1016/S1473-3099(14)70711-X. Epub 2014 Apr 9.

本文引用的文献

1
Risk factor for 31-day unplanned readmission to hospital in patients with pulmonary tuberculosis in China.中国肺结核患者 31 天内非计划性再入院的风险因素。
Saudi Med J. 2021 Sep;42(9):1017-1023. doi: 10.15537/smj.2021.42.9.20210281.
2
Tuberculosis incidence and mortality in people living with human immunodeficiency virus: a Danish nationwide cohort study.结核发病率和病死率在人类免疫缺陷病毒感染者中:丹麦全国队列研究。
Clin Microbiol Infect. 2022 Apr;28(4):570-579. doi: 10.1016/j.cmi.2021.07.036. Epub 2021 Aug 24.
3
World Health Organization treatment outcome definitions for tuberculosis: 2021 update.世界卫生组织结核病治疗结果定义:2021年更新版
Eur Respir J. 2021 Aug 19;58(2). doi: 10.1183/13993003.00804-2021. Print 2021 Aug.
4
Six-year trend and risk factors of unsuccessful pulmonary tuberculosis treatment outcomes in Thai Community Hospital.泰国社区医院肺结核治疗结果未成功的六年趋势及风险因素
BMC Res Notes. 2021 Mar 9;14(1):89. doi: 10.1186/s13104-021-05504-z.
5
Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial.标准剂量拉替拉韦或依非韦伦为基础的抗逆转录病毒治疗方案用于 HIV 和结核病合并感染患者(ANRS 12 300 Reflate TB 2):一项开放标签、非劣效性、随机、3 期临床试验。
Lancet Infect Dis. 2021 Jun;21(6):813-822. doi: 10.1016/S1473-3099(20)30869-0. Epub 2021 Mar 2.
6
Anemia in tuberculosis cases: A biomarker of severity?结核病患者的贫血:严重程度的生物标志物?
PLoS One. 2021 Feb 2;16(2):e0245458. doi: 10.1371/journal.pone.0245458. eCollection 2021.
7
A retrospective cohort study of early mortality among patients with HIV/TB co-infection in Shanghai municipality.上海市 HIV/TB 合并感染患者早期死亡率的回顾性队列研究。
HIV Med. 2020 Dec;21(11):739-746. doi: 10.1111/hiv.13025.
8
Predictors of Adverse TB Treatment Outcome among TB/HIV Patients Compared with Non-HIV Patients in the Greater Accra Regional Hospital from 2008 to 2016.2008年至2016年大阿克拉地区医院中,与非艾滋病毒患者相比,艾滋病毒/结核病患者不良结核病治疗结果的预测因素
Tuberc Res Treat. 2020 Aug 4;2020:1097581. doi: 10.1155/2020/1097581. eCollection 2020.
9
Factors influencing the length of hospital stay during the intensive phase of multidrug-resistant tuberculosis treatment at Amhara regional state hospitals, Ethiopia: a retrospective follow up study.影响埃塞俄比亚阿姆哈拉州立医院耐多药结核病强化治疗阶段住院时间的因素:一项回顾性随访研究。
BMC Public Health. 2020 Aug 8;20(1):1217. doi: 10.1186/s12889-020-09324-x.
10
Tuberculosis bacillary load, an early marker of disease severity: the utility of tuberculosis Molecular Bacterial Load Assay.结核分枝杆菌载量,疾病严重程度的早期标志物:结核分子细菌载量测定的应用。
Thorax. 2020 Jul;75(7):606-608. doi: 10.1136/thoraxjnl-2019-214238. Epub 2020 Apr 30.